rxstat › Classes › Anti-parathyroid Hormones
Anti-parathyroid Hormones: shortage status in Canada
1 of the 2 anti-parathyroid hormones rxstat tracks is currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Cinacalcet (Sensipar) Partial shortage 10 of 24 reported products affected · est. return Dec 31, 2026
Calcitonin (Calcimar) Discontinued 0 of 1 reported products affected
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.